Search research articles
Contact Us
Filters
Showing results (151-160 of 578) with videos related to
Page
of 58
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 8, 2011
Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma
An Coosemans, Ben Van Calster, Godelieve Verbist, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 22, 2020
Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy
Liselore Loverix, Rawand Rokan Salihi, Els Van Nieuwenhuysen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Does paclitaxel-carboplatin chemotherapy in a dose-dense regimen enhance survival of BRCA-related ovarian cancer patients?
Karin Leunen, Isabelle Cadron, Toon Van Gorp, et al.
Frontiers in Medicine
|
October 27, 2022
Intraperitoneal alpha therapy with <sup>224</sup>Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model
Roxanne Wouters, Sara Westrøm, Yani Berckmans, et al.
Breast Cancer Research : BCR
|
April 8, 2015
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management
Eleni van Schooneveld, Hans Wildiers, Ignace Vergote, et al.
Obstetrics and Gynecology
|
October 22, 2011
Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay
Dirk Timmerman, Ben Van Calster, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 28, 2012
Role of neoadjuvant chemotherapy in the management of stage IIIC-IV ovarian cancer: survey results from the members of the European Society of Gynecological Oncology
Sarah Cornelis, Ben Van Calster, Frederic Amant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 10, 2016
Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients
Ivone Ribeiro, Hilde Janssen, Marisol De Brabandere, et al.
Gynecologic Oncology
|
March 19, 2013
Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG
Florian Heitz, Andreas du Bois, Philipp Harter, et al.
Gynecologic Oncology
|
May 5, 2010
The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells
Isabelle Cadron, Toon Van Gorp, Attila Mihalyi, et al.
Page
of 58
Search research articles
Search
Showing results (151-160 of 578) with videos related to
Sort By:
Page
of 58
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 8, 2011
Wilms tumor gene 1 (WT1) is a prognostic marker in high-grade uterine sarcoma
An Coosemans, Ben Van Calster, Godelieve Verbist, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 22, 2020
Para-aortic lymph node surgical staging in locally-advanced cervical cancer: comparison between robotic versus conventional laparoscopy
Liselore Loverix, Rawand Rokan Salihi, Els Van Nieuwenhuysen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
December 4, 2009
Does paclitaxel-carboplatin chemotherapy in a dose-dense regimen enhance survival of BRCA-related ovarian cancer patients?
Karin Leunen, Isabelle Cadron, Toon Van Gorp, et al.
Frontiers in Medicine
|
October 27, 2022
Intraperitoneal alpha therapy with <sup>224</sup>Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model
Roxanne Wouters, Sara Westrøm, Yani Berckmans, et al.
Breast Cancer Research : BCR
|
April 8, 2015
Dysregulation of microRNAs in breast cancer and their potential role as prognostic and predictive biomarkers in patient management
Eleni van Schooneveld, Hans Wildiers, Ignace Vergote, et al.
Obstetrics and Gynecology
|
October 22, 2011
Performance of the American College of Obstetricians and Gynecologists' ovarian tumor referral guidelines with a multivariate index assay
Dirk Timmerman, Ben Van Calster, Ignace Vergote, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
February 28, 2012
Role of neoadjuvant chemotherapy in the management of stage IIIC-IV ovarian cancer: survey results from the members of the European Society of Gynecological Oncology
Sarah Cornelis, Ben Van Calster, Frederic Amant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 10, 2016
Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients
Ivone Ribeiro, Hilde Janssen, Marisol De Brabandere, et al.
Gynecologic Oncology
|
March 19, 2013
Impact of beta blocker medication in patients with platinum sensitive recurrent ovarian cancer-a combined analysis of 2 prospective multicenter trials by the AGO Study Group, NCIC-CTG and EORTC-GCG
Florian Heitz, Andreas du Bois, Philipp Harter, et al.
Gynecologic Oncology
|
May 5, 2010
The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells
Isabelle Cadron, Toon Van Gorp, Attila Mihalyi, et al.
Page
of 58